What about the Children?  

Lynda Shentall, University of Salford.


Vertical HIV Transmissions in the UK- insights and remaining challenges
Authors: Helen Peters (1), Kate Francis (1), Laura Smeaton (2), Claire Thorne (1) on behalf of the ISOSS HIV Clinical Expert Review Panel
(1) Integrated Screening Outcomes Surveillance Service, UCL Great Ormond Street Institute of Child Health
(2) Infectious Diseases in Pregnancy Screening Programme, Public Health England


DOLUTEGRAVIR-BASED ART IS SUPERIOR TO NNRTI/PI-BASED ART IN INFANTS, CHILDREN AND ADOLESCENTS

Anna Turkova on behalf of the ODYSSEY Trial Team


Virological failures and genotypic resistance in children and adolescents randomised to dolutegravir-based ART vs. standard-of-care in the ODYSSEY trial

Authors: Ellen White (1) and Cissy Kityo (2) on behalf of the ODYSSEY team 

Authors’ affiliations: (1) MRC CTU at UCL, London, United Kingdom; (2) Joint Clinical Research Centre, Kampala, Uganda